(Q24799647)

2

0 references

Loredana Bocchino

3

0 references

Lucia Morgante

4

0 references

Donatella Sangari

5

0 references

Irene Castagna

6

0 references

Gian Filippo Bagnato

BMC Musculoskeletal Disorders

7

0 references

language of work or name

English

0 references

publication date

28 August 2003

0 references

published in

0 references

volume

4

0 references

issue

1

0 references

page(s)

19

0 references

exact match

https://scigraph.springernature.com/pub.10.1186/1471-2474-4-19

1 reference

9 September 2019

https://scigraph.springernature.com/pub.10.1186/1471-2474-4-19

cites work

Behçet's disease: a new target for anti-tumour necrosis factor treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=194711

Treatment of intestinal Behçet's syndrome with chimeric tumour necrosis factor alpha antibody

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=194711

Treatment of Behçet's disease--an update

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=194711

Anti-tumor necrosis factor monoclonal antibody therapy for gastrointestinal Behçet's disease: a case report

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=194711

Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study Group

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=194711

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=194711

Chimeric anti-TNF-alpha monoclonal antibody cA2 binds recombinant transmembrane TNF-alpha and activates immune effector functions

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=194711

Anti-tumour necrosis factor monoclonal antibody treatment for ocular Behçet's disease

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=194711

Remission of Behçet's syndrome with tumour necrosis factor alpha blocking therapy

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=194711

Criteria for diagnosis of Behcet's disease

30 May 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2474-4-19

Remission of Behçet's syndrome with TNFalpha blocking treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2474-4-19

Effect of infliximab on sight-threatening panuveitis in Behçet's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2474-4-19

Role of gammadelta T lymphocytes in the development of Behçet's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2474-4-19

Treatment of recalcitrant orogenital ulceration of Behçet's syndrome with infliximab

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2474-4-19

Effect of infliximab on threatening panuveitis in Behçet's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2474-4-19

Behçet's syndrome: response to infliximab after failure of etanercept

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2474-4-19

Behçet's disease: an update on the pathogenesis

21 January 2018

1 reference

12 December 2020

Behçet's ileocolitis: successful treatment with tumor necrosis factor-alpha antibody (infliximab) therapy: report of a case

1 reference

12 December 2020

Criteria for diagnosis of Behçet's disease. International Study Group for Behçet's Disease

1 reference

12 December 2020

Immunopathological aspects of Behçet's disease

1 reference

12 December 2020

Systemic levels of the T cell regulatory cytokines IL-10 and IL-12 in Bechçet's disease; soluble TNFR-75 as a biological marker of disease activity

1 reference

12 December 2020